Skip to content

Study · Not a test of the peptide alone · 1988

1 result

A radioimmunoassay for parathymosin alpha using antibodies to synthetic N-terminal peptide 1-30.

Tsitsiloni OE, Yialouris PP, Heimer EP, Felix AM, Evangelatos GP, Soteriadis-Vlahos C, Stiakakis J, Hannappel E, Haritos AA

Journal of immunological methods1 Oct 1988Cited by 8 (Europe PMC)

PMID3049827 (opens in a new tab)DOI10.1016/0022-1759(88)90330-4 (opens in a new tab)PepBankPUB-03049827
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneIn vitro (cell-free)Other

    The antiserum used in a parathymosin alpha radioimmunoassay did not cross-react with thymosin alpha‑1 at the same molar concentrations.

    In plain wordsIn lab tests, an antibody for parathymosin alpha did not react with thymosin alpha‑1.

    Peptide
    Thymosin alpha-1
    Outcome
    No significant changeCross-reactivity of parathymosin alpha antiserum with thymosin alpha 1
    Study

    n: not reported in source

    Radioimmunoassay with rabbit antiserum
    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    The antiserum failed to crossreact with the same molar concentrations of the partly homologous thymosin alpha 1 or prothymosin alpha.

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.